Good Hospitals with Embryology Labs in Georgia: Evaluation Criteria & Selection Guide

Opening: Real Consultation Scenario

Consultation Scenario A 41-year-old woman with diminished ovarian reserve asked online: "I understand Georgia's laws are relatively relaxed, but I'm not sure about the actual level of their embryology labs. I had one IVF cycle in my home country before, and the embryos stopped developing on day 3. So this time, I'm particularly concerned about whether the lab can culture my embryos to the blastocyst stage." This question points to the most critical technical aspect of an assisted reproduction cycle—the capability of the embryology lab directly determines whether a transferable embryo can be obtained, especially for individuals of advanced age, with diminished ovarian reserve, or with a history of abnormal embryo development.

Module A: Direct Answer to the Question

Four Core Dimensions for Evaluating an Embryology Lab in Georgia

Assisted reproductive institutions in Georgia vary significantly in their lab configurations, and generalizations cannot be made. To determine if a hospital's embryology lab is reliable, verification should be conducted item by item based on the following four dimensions:

• Lab Accreditation & Quality Control System — Whether it holds internationally recognized quality certifications (e.g., ISO 15189, CAP, or relevant ESHRE standards); whether it has regular internal QC reports and external quality assessment (EQA) records.
• Experience & Stability of the Embryology Team — The embryologists' years of experience, training background (whether trained at renowned centers in Europe or North America), and team turnover rate. The embryologist's experience directly impacts ICSI fertilization rates, blastocyst culture success rates, and embryo biopsy quality.
• Culture System & Equipment Configuration — Whether time-lapse incubators, low-oxygen culture environment (5% O₂), and stable air purification with temperature/humidity monitoring systems are used. These hardware conditions are crucial for embryo developmental potential.
• Data Transparency & Authenticity — Whether the hospital is willing to provide verifiable annual lab data, including fertilization rates, blastocyst formation rates, transferable embryo rates after PGT screening, and live birth rates stratified by age. Institutions that refuse to provide specific data or only offer "overall success rates" should be approached with caution.

Module C: The Doctor's Perspective

Lab Selection from the Doctor's Decision-Making Logic

In the field of assisted reproduction, the collaboration between the clinician and the embryology lab is the cornerstone of cycle success. An experienced reproductive doctor will focus on the following three points when choosing a partner lab:

• "Individualized" Embryo Culture Capability: For patients with a history of embryo developmental arrest, severe fragmentation, or abnormal fertilization, whether the lab can adjust the culture protocol (e.g., using sequential culture, altering oxygen concentration, or adding specific growth factors) is a hidden criterion for doctors to judge the lab's level.
• Stability & Accuracy of PGT Technology: If the patient requires embryo genetic screening or diagnosis, the lab must have a stable embryo biopsy capability (Day 5/6 trophectoderm biopsy) and a smooth collaboration process with the genetics lab. The post-biopsy embryo survival rate should be ≥95%, and the consistency of test results needs to be validated.
• Information Loop Between Lab and Clinic: Doctors need the lab to provide a detailed embryo development log—including fertilization time, cleavage pattern, blastocyst expansion degree, and inner cell mass/trophectoderm grade for each embryo. The more complete the information, the more precise the doctor's transfer decision.

Module F: Differences Between Hospitals

Differences in Embryology Labs Across Georgian Hospitals

Based on hardware configuration, technical team, and operational standards, fertility centers in Georgia can be roughly divided into three categories. The table below summarizes their typical characteristics for reference:

Category	Lab Features	Commonly Found In	Suitable For
Category 1: Internationally Certified Centers	Hold ISO or CAP certification; use time-lapse incubators + low oxygen culture; embryologists with ≥10 years experience; have an independent PGT lab or stable partner center; annual data publicly available.	A few top-tier private fertility centers (e.g., Chachava Clinic, Beta Clinic, New Life Georgia, etc.)	Patients of advanced age, with poor previous cycle embryo development, needing PGT, or with high demands on the lab.
Category 2: Standardized Labs	Have basic QC systems; use conventional incubators + low oxygen culture; embryologists with 5-10 years experience; PGT sent out; data partially disclosed.	Most medium-sized fertility centers	Patients aged <38 years, with normal ovarian function, and no history of poor embryo development.
Category 3: Basic Configuration Labs	Use standard incubator models; low oxygen culture not routinely used; few embryologists with limited experience; data opaque or unverifiable.	Some small or newly established institutions	Suitable only for very simple cases, and requires additional due diligence on the lab.

It should be noted that the above classification is not fixed. Some Category 2 labs are upgrading their equipment, while Category 1 labs may experience quality fluctuations due to the departure of key embryologists. Therefore, dynamically verifying the current status of the lab is more important than relying on the institution's name.

Module G: Most Easily Overlooked Details

Most Easily Overlooked Details: The Lab's "Soft Power"

Many people only focus on whether a lab has time-lapse or can perform PGT when evaluating it, but the following details are equally critical and often ignored:

• Daily Workflow & Staff-to-Cycle Ratio: How many cycles of embryo manipulation does one embryologist handle per day? If the workload per person is too high, it may lead to a decline in operational quality. A reasonable ratio is for each embryologist to handle no more than 3-4 cycles of key operations (e.g., ICSI, biopsy) per day.
• Incubator Alarm & Emergency Systems: Do the incubators have 24-hour monitoring and alarms for temperature, CO₂, and O₂? Are there backup generators and reserve incubators? What is the lab's emergency plan in case of power outage or equipment failure? These details directly relate to embryo safety.
• Embryo Freezing & Thawing Survival Rates: If planning for frozen embryo transfer, request the lab's embryo freezing and thawing survival rates for the past 12 months. The clinically acceptable standard is a survival rate ≥90%, and a post-thaw re-expansion rate ≥70%.
• Participation in External Quality Assessment (EQA): For example, whether the lab regularly participates in EQA programs from the European Society of Human Reproduction and Embryology (ESHRE) or the College of American Pathologists (CAP). Participation in external QC is an important marker of lab quality control.

Module H: Most Common Pitfalls

Most Common Pitfalls: Data Interpretation & Information Asymmetry

When consulting about embryology labs in Georgia, be particularly wary of the following three "traps":

• Misled by "High Success Rates": Some institutions publish an overall pregnancy rate (e.g., "70%"), but this data may only include young patients with normal ovarian function, or may not differentiate between fresh and frozen embryos, or may not include cycles with no eggs retrieved. Reliable institutions provide data stratified by age and diagnosis, and clearly state the denominator (all patients starting the cycle) and numerator (patients achieving live birth).
• Ignoring the Embryologist's Actual Experience: The institution's brochure may list several embryologists' names, but the person actually handling your cycle might be a junior staff member with limited experience. It is recommended to specify in the agreement that at least one senior embryologist will be responsible for all key operations throughout the cycle, and include this in the informed consent form.
• Misunderstanding "PGT Lab": Some institutions claim to have an "in-house PGT lab," but it may only be a sample transfer station, with the actual genetic testing done by a third-party platform. It is necessary to distinguish between "embryo biopsy capability" (the lab's own technology) and "genetic testing capability" (which depends on the collaborating genetics institution).

Module I: Practical Process

Practical Process: How to Verify the True Level of an Embryology Lab

For patients planning assisted reproduction in Georgia, it is recommended to conduct a background check on the target hospital's embryology lab using the following process:

• Step 1: Request Lab QC Documents — Ask for the lab's accreditation certificate (if any), a list of internal QC standard operating procedures (SOPs), and EQA reports for the past 12 months. Reputable labs usually provide a de-identified version.
• Step 2: Arrange a Remote Meeting with the Embryologist — Via video conference, discuss your previous embryo development directly with the embryologist who will handle your cycle, and ask for their initial thoughts on the culture protocol. An experienced embryologist will ask targeted questions rather than giving vague assurances.
• Step 3: Request a Personalized Culture Plan — Based on your age, AMH level, and previous embryo development records, the lab should be able to provide a detailed culture plan, including: the type of incubator to be used, culture media brand, whether low oxygen culture will be used, Day 3 assessment criteria, blastocyst biopsy timing, etc.
• Step 4: Confirm the Data Tracking System — Ask what electronic embryo tracking system (e.g., RI Witness or equivalent) the lab uses to ensure no sample mix-ups during procedures. This is a basic requirement for lab quality management.

Module L: Interpretation of Key Indicators

Key Indicator Interpretation: How to Read Lab Data

When evaluating data provided by a lab, focus on the following indicators and their clinical significance:

Indicator	Meaning	Clinically Acceptable Range	Indicates Lab Level
Fertilization Rate (2PN Rate)	Proportion of eggs normally fertilized after ICSI	70-80%	Reflects ICSI operation quality and egg quality
Blastocyst Formation Rate	Proportion of fertilized eggs developing to Day 5/6 blastocysts	40-60% (depends on patient age)	Reflects culture system and lab conditions
Post-Biopsy Blastocyst Survival Rate	Proportion of embryos surviving and continuing development after biopsy	≥95%	Reflects embryologist's biopsy technique
Freeze-Thaw Survival Rate	Proportion of frozen embryos surviving thawing with unchanged morphological score	≥90%	Reflects stability of freezing and thawing protocols
PGT Transferable Embryo Rate	Proportion of embryos deemed transferable after genetic screening	Varies by age and diagnosis (30-60%)	Must be interpreted in conjunction with patient age and diagnosis

Note: The above data should be based on the same institution's actual records for the past 12 months and stratified by patient age. If an institution can only provide an "overall average" without stratified data, its reference value is significantly diminished.

Module R: Practitioner's Observation

Practitioner's Observation: Hidden Signals of Lab Quality Assessment

As a technician with long-term exposure to assisted reproduction labs, I believe the following signals can help quickly assess a lab's management level:

• Whether the lab allows patient visits (via glass window or video link) — Transparent labs are usually more confident and indicate good clean zone separation in the operational area.
• Whether the lab uses electronic medical records and embryo tracking systems — Labs relying entirely on paper records may pose risks regarding data integrity and traceability.
• Whether the lab is willing to provide analysis of failed cases — Teams that can openly discuss reasons for past cycle failures (e.g., "The blastocyst formation rate was lower than expected in that cycle, and we conducted the following review...") usually have a more mature quality improvement culture.
• The lab's "temperature" — Does the embryologist know the details of your case? Do they use specific embryology terminology during communication, or only give templated answers? This reflects their emphasis on individualized treatment.

Closing: Reminder for Special Populations